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Abstract
Background: Successful dental and orthopedic implants require the establishment of an intimate association with bone
tissue; however, the mechanistic explanation of how biological systems accomplish osseointegration is still incomplete. We
sought to identify critical gene networks involved in osseointegration by exploring the implant failure model under vitamin
D deficiency.
Methodology: Adult male Sprague-Dawley rats were exposed to control or vitamin D-deficient diet prior to the osteotomy
surgery in the femur bone and the placement of T-shaped Ti4Al6V implant. Two weeks after the osteotomy and implant
placement, tissue formed at the osteotomy site or in the hollow chamber of T-shaped implant was harvested and total RNA
was evaluated by whole genome microarray analyses.
Principal Findings: Two-way ANOVA of microarray data identified 103 genes that were significantly (.2 fold) modulated by
the implant placement and vitamin D deficiency. Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses assigned the
highest z-score to the circadian rhythm pathway including neuronal PAS domain 2 (NPAS2), and period homolog 2 (Per2).
NPAS2 and Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/Bmal 1) were upregulated around implant and
diminished by vitamin D deficiency, whereas the expression pattern of Per2 was complementary. Hierarchical cluster
analysis further revealed that NPAS2 was in a group predominantly composed of cartilage extracellular matrix (ECM) genes.
Whereas the expression of bone ECM genes around implant was not significantly affected by vitamin D deficiency, cartilage
ECM genes were modulated by the presence of the implant and vitamin D status. In a proof-of-concept in vitro study, the
expression of cartilage type II and X collagens was found upregulated when mouse mesenchymal stem cells were cultured
on implant disk with 1,25D supplementation.
Conclusions: This study suggests that the circadian rhythm system and cartilage extracellular matrix may be involved in the
establishment of osseointegration under vitamin D regulation.
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Introduction
Increasing numbers of dental and orthopedic procedures
require the implantation of foreign materials into bone to replace
missing or damaged body parts. These implants are made of
mechanically sustainable metals such as titanium (Ti) that may be
treated to generate surface microtopography or coated with
calcium phosphates such as hydroxyapatite (HA). To be successful
and functional, these endosseous implants have to establish an
intimate integration of bone and implant that is referred to as
osseointegration [1,2]. To date, the mechanisms of osseointegra-
tion have been largely explored from the prospective of bone
wound healing [3,4,5]. However, recent investigations have
indicated that the placement of implant into bone activates a
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wide range of biological reactions [6,7,8,9], not limited to those of
bone remodeling. Therefore, osseointegration may be a complex
process involving a number of mechanistic systems, some of which
have not yet been identified.
While the prevalence of implant failure is small in dentistry
[10,11], understanding the biological basis for these rare cases
should provide novel insights into the mechanisms underlying
osseointegration. For example, a striking rate of implant failure has
been reported in X-linked hypophosphatemic rickets (XLH)
patients [12]. XLH is an X-linked dominant disorder highlighted
by renal defects in phosphate reabsorption with various bone
manifestations (Online Mendelian Inheritance in Men, #307800).
XLH is associated with an incomplete defect in the regulation of
25-hydroxyvitamin D-1-alpha-hydroxylase, a critical enzyme to
activate vitamin D [13]. Separately, Kelly et al. (2009) reported
that the rate of implant osseointegration characterized by the
upholding mechanical load and histological bone to implant
contact ratio was significantly impaired in vitamin D-deficient rats
[14]. Vitamin D is a steroid hormone that participates in broad
physiological actions [15,16,17,18]. Abnormal vitamin D-related
regulations have resulted in skeletal diseases such as rickets and
osteomalacia [19,20], catabolic bone remodeling [20,21,22],
autoimmune diseases [23], and increased susceptibility to
infectious diseases [24]. However, the role of vitamin D in the
establishment of osseointegration has not been addressed.
Based on these previous data, we have hypothesized that the
critical biological mechanism responsible for osseointegration may,
in part, be dependent upon vitamin D. The exploration of how
vitamin D deficiency alters osseointegration should provide a
unique experimental platform to elucidate its mechanisms.
Furthermore, this work has a clinical relevance as the prevalence
of vitamin D deficiency has been reported increasing in the
populations worldwide [25,26,27]. Recently, the prevalence of
vitamin D deficiency was found to be high even in the adolescent
population with disproportionate burden falling on the non-
Hispanic blacks [28]. The present study was designed to broadly
characterize the transcriptional changes that occur as a result of
implant placement into the bone of vitamin D-deficient and
control rats using a whole genome microarray screening. We
report here an unexpected identification of a gene network
composed of circadian rhythm systems and cartilage extracellular
matrix genes, which may participate in the establishment of
osseointegration under vitamin D regulation.
Results
Impaired osseointegration in vitamin D deficient rats
The present study used Sprague-Dawley rats that were
subjected to the vitamin D deficient protocol [29] prior to the
implant placement and throughout the study. Both vitamin D
sufficient control (V+) and deficient (V-) rats received T-shaped
experimental implant with a hollow inner chamber (Figure 1A) in
the femur (ITV+ and ITV- groups). Blood serum analyses
demonstrated the significant reduction of circulating precursor
vitamin D (25-hydroxy vitamin D3: 25D) with hypophosphoremia
in the vitamin D deficient (V-) group. There was a tendency of
increased serum parathyroid hormone and decreased serum
calcium level in the V- group (Figure 1B), whereas serum levels
of magnesium, triglycerides and glucose were not affected (data
not shown).
T-shaped implant has been used for the stringent evaluation of
implant-induced de novo tissue formation and osseointegration
[30,31]. The implant surface was treated with dual acid-etching
and HA nanoparticles [32], which has been shown more sensitive
to vitamin D-dependent regulation [14] and thus should be
suitable for the present study. Non-decalcified histology of ITV+
rats indicated the establishment of osseointegration in the implant
hollow chamber (Figure 1C). The morphometric measurement of
bone volume as well as bone-implant contact (Figure 1D) was
equivalent to recently reported data with the similar implant
surface characteristics [30]. Strikingly, while the volume of bone
growth in the implant hollow chamber of the ITV- group was
similar to that of the control ITV+ group, the bone to implant
contact was significantly impaired in the ITV- group (Figure 1D).
These observations suggest that the implant and bone integration
critical for the establishment of osseointegration was significantly
impaired by vitamin D deficiency in this model.
Two-way ANOVA analysis
Two-way ANOVA with Benjamini and Hochberg correction
revealed 103 transcripts that were differently expressed under the
studied conditions. The affected genes were differentially
expressed under healing effect of with or without implant. This
trend was generally consistent with the previous study [9] and thus
validated our model. The two-way ANOVA analysis further
identified 4 transcripts whose expression was altered by vitamin D
deficiency (P,0.05) and 3 transcripts whose expression was altered
by the interaction between vitamin D deficiency and implant
factors (P,0.05) (Table 1). Among the VD-deficiency altered-
gene list, we found Neuronal PAS domain 2 (NPAS2) and Period
Homolog 2 (Per2) as the most significantly affected genes by
vitamin D deficiency in the peri-implant tissue (Table 1).
KEGG analysis
The possible relation, co-regulation and function of 103 altered
genes were further investigated by the Kyoto Encyclopedia of
Genes and Genomes (KEGG) analyses. KEGG Pathway is a
collection of online databases for systematic analysis of gene
functions in the known molecular pathways [33]. The KEGG
analysis revealed genes involved in 6 distinct pathways for the
genes differently expressed under healing effect, and 1 pathway
that were over-represented when we considered the effect of V-
alone (Table 2). These identified KEGG pathways included:
circadian rhythm, formation of extracellular matrix (ECM-
receptor interaction, arginine and proline metabolism, and
glycerolipid metabolism), and xenobiotics biodegradation and
metabolism (1- and 2-Methylnaphthalene degradation) (Table 2).
Among these pathways, it was found that circadian rhythm was
most significantly altered by implant placement (z-score: 7.65) and
V- condition (z-score: 22.81).
Hierarchical Cluster analysis revealed a gene network
containing NPAS2 and cartilage matrix genes
The transcripts that were statistically different and had above
2.0-fold change in the two-way ANOVA analysis were grouped
into hierarchical clusters (Figure 2A). The analysis resulted in 5
hierarchical clusters with various sizes. Each cluster contained at
least 1 gene of transcripts that were identified by the KEGG
analysis. The clusters 1 to 3 were composed of genes that were
upregulated by the implant placement, whereas the clusters 4 and
5 contained downregulated genes by the implant placement. In
general, vitamin D deficiency attenuated the implant-induced
gene modulation.
The cluster 2 contained the transcripts most significantly
influenced by vitamin D deficiency, which consisted of 19 genes
including NPAS2 and the disproportionately large representation
of cartilage extracellular matrix (ECM) genes such as type II, type
Genome-Wide Screening of Osseointegration
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Figure 1. T-shaped implant placed in vitamin D sufficient (V+) and deficient (V-) rats. A. T-shaped experimental implant with a hollow
inner chamber was fabricated with Ti6Al4V and the implant surface was treated with dual acid-etching and discrete deposition of HA nanoparticles.
T-shaped implant was placed in the osteotomy site of the distal end of rat femur. B. Serum chemistry evaluations of 25-hydroxy vitamin D3 (25D),
parathyroid hormone (PTH), calcium (Ca), and phosphorous (P). *: p,0.05. C. Non-decalcified histology of bone tissues grew in the inner chamber of
T-shaped implant. The bone tissue (arrows; green in Goldner’s Masson Trichrome staining) was closely adhered to the implant surface in V+ rats. In V-
rats, the intimate bone-implant was not observed; and instead, implant surface was associated with fibrous connective tissue (arrowheads; red
staining). D. Histomorphometric characterization of bone volume and bone-implant contact within the inner chamber. *p,0.05.
doi:10.1371/journal.pone.0015848.g001
Table 1. Significantly modulated genes identified by Two-way ANOVA for the vitamin D deficiency effect.
Effects Gene Title Gene ID
Vitamin D Neuronal PAS domain 2 (NPAS2) CO386194
Period homolog 2 (Per2) NM031678
Visinin-like 1 NM_012686
TSC22d3 (GILZ) AI029054, NM031345
Implant-Vitamin D Interaction CEA-related cell adhesion molecule 1 BF420163
CD226 antigen XM_225664
Copine IV, transcript variant 3 XM_001070003
doi:10.1371/journal.pone.0015848.t001
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X and type IX collagen alpha chains, hyaluronan-proteoglycan
link protein and dermatan sulfate proteoglycan 3 (Figure 2B).
The cluster 3 contained Per2 and Aryl hydrocarbon receptor
nuclear translocator-like (ARNTL, a.k.a Bmal1).
The hierarchical clustering re-evaluated by directionality
indicated that upregulated NPAS2 and cartilage ECM genes by
the implant placement were completely attenuated by vitamin D
deficiency. On the contrary, the cluster containing Per2 was
upregulated by vitamin D deficiency and showed a complemen-
tary expression pattern to the NPAS2 cluster (Figure 2C).
Expression of cartilage and bone extracellular matrix-
related genes
The hierarchical cluster analysis revealed the potential close
association between NPAS2 and cartilage ECM genes. When the
microarray data of ITV+ and ITV- groups were re-evaluated by t-
test without Benjamini and Hochberg correction, it was found that
nearly all cartilage ECM-related genes were significantly down-
regulated in the ITV- group, whereas none of bone ECM-related
genes were affected (Figure 3A and Table 3). The microarray
data were confirmed by RTPCR (Figure 3B).
Increased synthesis of cartilage matrix molecules by
mouse bone marrow mesenchymal stem cells cultured
with implant disk and vitamin D supplementation in vitro
To investigate the observed upregulation of cartilage ECM
genes in the peri-implant tissue, a proof-of-concept in vitro study
was performed. The expression of cartilage ECM-related genes
such as type II and type X collagens was significantly upregulated
when mouse bone marrow mesenchymal stem cells (D1 ORL
UVA [D1]; D1 cells) were cultured with implant disk (Figure 4A).
Furthermore, the 1,25-dihydroxyvitamin D (1,25D) supplementa-
tion accelerated the timing of type II and type X collagen
expression, whereas the expression of Sox9 was not affected by
implant disk nor 1,25D supplementation (Figure 4A). In contrast,
the expression of bone ECM-related genes such as type I collagen,
osteonectin and Runx2 (Figure 4A) as well as osteocalcin and
osteopontin (data not shown) was only modestly increased with the
presence of implant disk. The 1,25D supplementation also showed
mild effect on the expression of bone matrix-related genes.
The presence of implant disk and 1,25D supplementation
increased the expression of NPAS2 in vitro; however, their effect
was not clearly observed during the early culture periods
(Figure 4B). We examined if there was any association between
NPAS2 and the increased expression of cartilage ECM; i.e., type II
and type X collagens. The application of a commercially available
siRNA targeting NPAS2, not the negative control siRNA,
demonstrated approximately 70,80% reduction of the steady
state NPAS2 mRNA level (Figure 4C). The siRNA-derived
NPAS2 knockdown resulted in the significant decrease of the type
II and type X collagen mRNA levels, when D1 cells were
maintained in the 1.25D supplemented culture medium with
implant (Figure 4D). In fact, NPAS2 knockdown normalized the
elevated type II collagen expression induced by the presence of
implant disc. On the contrary, the NPAS2 siRNA treatment did
not completely normalize the type X collagen expression of D1
cells cultured with implant disc. D1 cells cultured without implant,
NPAS2 knockdown did not affect type II collagen expression; but
unexpectedly, increased the type X collagen mRNA level.
Immuno-identification of type X collagen network on the
implant disk was positively associated with 1,25D supplementation
(Figure 5A). While identifiable, type X collagen network was less
developed without 1,25D supplementation; however, when D1
cells were cultured without the implant disk, type X collagen was
not detected. The average cell size was increased by the placement
of implant disk and 1,25D supplementation (Figure 5B).
In an additional experiment, we further evaluated the presence
of type X collagen in the interacting tissues with implant. T-shape
implants were harvested from the femur of control rats 2 weeks
after the surgical placement and the external implant surface was
immunohistologically evaluated after major bone tissues were
removed. Confocal laser scanning microscopy clearly detected the
presence of type X collagen epitopes and found that these epitopes
were disproportionately localized in the presumptive intermediate
tissue between bone and implant (Figure 5C). Where clusters of
cells still remained, type X collagen was either absent or showed a
positive staining similar in appearance to that found in the in vitro
study. In the area of presumptive bone-implant interface, type X
collagen appeared to be organized into the well-defined extracel-
lular matrix with a hexagonal structure (Figure 5C).
Discussion
This study, for the first time, provided the stringently
determined network of genes that were associated with success
and failure of implant osseointegration. The novel design of the
present investigation was to comparatively evaluate the whole
genome microarray associated with implant placement in vitamin
D-deficient and control rats. Initially, we anticipated finding genes
that were involved in the classic category of bone remodeling;
however, in two-way ANOVA, we found NPAS2 as the most
significantly affected gene by vitamin D deficiency in the peri-
implant tissue. NPAS2 is a member of the basic helix-loop-helix-
PAS family of transcription factors, involved in the regulation of
circadian rhythm [34]. The primary molecular target of NPAS2 is
Per2, which was also found to be significantly modulated by
vitamin D deficiency in the peri-implant tissue (Table 1).
Furthermore, KEGG (Table 2) pathway analyses also
highlighted the potential involvement of the circadian rhythm
system in the establishment of osseointegration. Circadian
oscillations are generated by a core set of genes: NPAS2, Per2
as well as ARNTL/Bmal1 that are part of a negative feedback
loop and are referred to as ‘‘clock’’ genes [34]. These genes are
widely expressed throughout the body tissues and are likely
involved the temporal patterning of local gene transcription
[35,36]. In the present study, NPAS2 was upregulated in the peri-
implant tissue, which was completely attenuated under the vitamin
D-deficient condition. In contrast, the vitamin D-deficient
environment significantly increased the expression of Per2
(Table 3). The reevaluation of microarray data of ITV+ and
ITV- groups by t-test further identified Arntl/Bmal1 that was
significantly downregulated in the ITV- group (Table 3).
Table 2. Representative KEGG Pathways with z-score .2.0.
Effects KEGG Pathway z-score
Implant Circadian rhythm 7.65
Neuroactive ligand-receptor interaction 4.64
1- and 2-Methylnaphthalene degradation 3.34
Arginine and proline metabolism 2.99
ECM-receptor interaction 2.65
Glycerolipid metabolism 2.50
Vitamin D Circadian rhythm 22.81
doi:10.1371/journal.pone.0015848.t002
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Figure 2. Hierarchical cluster analysis. A. Two-way ANOVA resulted in a total of 103 genes, which were further grouped into 5 clusters (Cluster 1
to 5). B. Cluster 2 contained NPAS2 (arrow), one of the most significantly affected genes, as well as cartilage ECM genes (arrowheads). C. Directional
hierarchical clustering revealed that the NPAS2 and Per2 clusters behaved in a complementary fashion.
doi:10.1371/journal.pone.0015848.g002
Genome-Wide Screening of Osseointegration
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Previous work has shown the rhythmic expression of clock genes
in osteoblasts and found that mutant mice lacking these clock
genes exhibit altered osteoblast proliferation [37]. Other studies
have found evidence for circadian regulation of cell cycle and cell
proliferation [38,39]. In the present study, we found the evidence
that the placement of the implant into bone alters the expression of
genes involved in circadian regulation. The experimental implant
was fabricated from Ti alloy with submicron surface topography.
Approximately 50% of the implant surface was further modified
by HA nanoparticles [30,32,40,41]. Ti implants have been long
considered bio-inert; however, recently, Ogawa and colleagues
have demonstrated that UV treatment of Ti implant can activate
the surface energy, which underscores the functional involvement
of electrostatic mechanism [42]. The implant surface further
contains complex carbon molecules such as polyaromatic
hydrocarbons (PAHs) [43]. It may be possible that the implant
material could induce biological responses such as electrostatic or
xenobiotics responses. NPAS2, Per2 and Arntl/Bmal1 responsible
for circadian rhythm control contain PAS (Per-Arnt-Sim) motifs. It
has been suggested that PAS-containing transcription factors are
also responsible for the adaptation to environmental cues such as
the metabolism of xenobiotics and hypoxia signaling [44,45]. It is
tempting to speculate that the microenvironment induced by the
placement of implant may influence the disproportionate up-
regulation of circadian rhythm genes, in particular NPAS2.
More surprising observation was the extent to which vitamin D
deficiency also profoundly altered the expression of circadian
rhythm-related genes. Previous work has found evidence that
transcript for a vitamin D receptor is expressed with a daily
rhythm, at least in brown adipose tissue [46]. Still, the pervasive
impact of implant placement and vitamin D deficiency on
circadian rhythm-related gene expression in the bone matrix is a
novel finding.
Hierarchical clusterization is a holistic approach based on the
calculation and comparison of pairwise correlation coefficients
between two datasets to arrange genes according to similarity or
closeness in expression pattern [47]. NPAS2 and seemingly
unrelated cartilage ECM genes such as col2a1, aggrecan, and
col10a1 were co-localized in a small cluster (Figure 2B). This
finding was unexpected, but could suggest a novel co-regulatory
Figure 3. Expression of bone and cartilage extracellular matrix (ECM). A. Compiled microarray data of bone and cartilage ECM genes.
Cartilage ECM genes were more significantly affected by implant placement and vitamin D deficiency than bone ECM genes. B. Microarray data for
bone and cartilage ECM genes were confirmed by real time reverse transcription polymerase chain reaction (RTPCT).
doi:10.1371/journal.pone.0015848.g003
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mechanism affecting skeletal circadian rhythm system and
cartilage ECM gene expression. Bone wound healing associated
with implant osseointegration undergoes intramembranous bone
formation without cartilage precursor tissue [3,4]; therefore the
expression of cartilage ECM molecules during osseointegration
was a puzzling observation. RNA samples used for microarray
assay were reevaluated by RTPCR and confirmed the expression
of cartilage matrix ECM genes (Figure 3B); however, histological
cartilage tissue was not formed in the inner chamber of T-shaped
implant (Figure 1C).
Under hypoxic in vitro conditions, the expression of cartilage
ECM genes was reported to increase in bone marrow mesenchymal
stem cells, which expressed Sox9, an initiation factor of chondro-
genic differentiation [48,49]. Hypoxia-induced factor 1 alpha (HIF-
1a) has been shown to mediate the hypoxia-induced chondrogenic
differentiation [50,51]. Thus, we initially postulated that implant
placement might induce a relatively hypoxic local microenviron-
ment, inducing the observed upregulation of cartilage ECM genes.
However, reevaluation of the microarray data revealed that the
expression levels of HIF-1a and Sox9 were not significantly affected
in all groups (Table 3). Thus, the upregulation of cartilage ECM
genes associated with implant healing may employ different
mechanisms.
The expression of cartilage ECM during the establishment of
osseointegration has not been reported. We designed and
performed a proof-of-concept in vitro experiment to determine if
the placement of the implant affects the expression of cartilage
ECM. Mouse bone marrow D1 cells, when cultured on implant
disk with 1,25D supplementation, significantly accelerated the
expression of type II and type X collagens (Figure 4A). Although
the expression pattern of NPAS2 in this in vitro system did not
match with those of type II and type X collagens (Figure 4B), the
siRNA-derived knockdown study indicated that NPAS2 appeared
to regulate their expression (Figure 4D). Circadian rhythm
molecule ARNTL/Bmal1 is the obligatory partner of NPAS2 to
induce target genes through a cis-acting MOP3/MOP4 responsive
element (M34RE; CACGTGACC) [44]. It has been reported that
type II and type X collagen genes as well as aggrecan gene contain
active M34RE [52,53]. As such, we postulate that the ectopic
synthesis of cartilage ECM molecules around the implant may be
regulated by the activated NPAS2-ARNTL/Bmal1 heterodimer.
However, an unexpected discrepancy was found in the type X
Table 3. Unadjusted t-test of significantly modulated genes between ITV+ (n = 4) and ITV- (n = 4).
Gene Groups Gene Name Ratio* P-value
Circadian Rhythm-Related Neuronal PAS domain 2 (NPAS2) 3.96 D 0.00028
Period homolog 2 (Per2) 1.73 U 0.00852
Aryl hydrocarbon receptor nuclear translocator-like (ARNTL) 2.10 D 0.00071
Adrenergic receptor, alpha 2c 2.12 D 0.03321
Cartilage ECM-Related Type II collagen alpha 1 4.88 D 0.02847
Type IX collagen alpha 1 n.d.** --
Type IX collagen alpha 2 2.00 D 0.02495
Type IX collagen alpha 3 4.65 D 0.01270
Type X collagen alpha 1 12.47 D 0.01994
Type XI collagen alpha 1 2.04 D 0.04079
Hyaluronan and proteoglycan link protein 1 (Hapln1) 3.43 D 0.03612
Dermatan sulfate proteoglycan 3 3.15 D 0.00980
Aggrecan 2.07 D 0.01696
Sox9 n.d. --
Catenin n.d. --
Bone ECM-Related Type I collagen alpha 1 n.d. --
Type I collagen alpha 2 n.d. --
Type V collagen alpha 1 n.d. --
Type V collagen alpha 2 n.d. --
Type V collagen alpha 3 n.d. --
SPP1 (Osteopontin) n.d. --
Osteocalcin n.d. --
SPARC (Osteonectin) n.d. --
Matrix Gla Protein n.d. --
Alkaline phosphatase n.d. --
Runx2 n.d. --
Hypoxia-Related Hypoxia-inducible factor 1 alpha n.d. --
Heat shock protein 1 1.61 D 0.03421
*Average gene expression ratio from microarray data analyzed by GeneSifter. D = down-regulated in ITV-; U = up-regulated in ITV-.
**n.d. = not detected within the threshold of 1.5-fold change.
doi:10.1371/journal.pone.0015848.t003
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collagen expression modulated by NPAS2 knockdown when D1
cells were cultured without implant. We speculate that NPAS2-
ARNTL/BmalI may regulate this gene as either an enhancer or a
silencer and the implant placement may disproportionately
activate its anabolic function.
The presence of type X collagen protein associated with implant
substrate in vitro (Figure 5A) and in vivo (Figure 5C) further
provides the supporting evidence that the presence of implant
material may alter the cellular behavior and induce the ectopic
synthesis of cartilage ECM molecules. With 1,25D supplementa-
tion, D1 cells on implant disk further spread to formmore polygonal
than spindle shapes. Moreover, the type X collagen found in the
presumptive bone-implant interface showed a well-defined hexag-
onal structure (Figure 5C). Kwan et al. (1991) reported that type X
collagen assembled into a mat-like structure in vitro, and the
prolonged incubation resulted in the formation of a hexagonal
lattice [54]. Therefore, although macromolecular organization of
type X collagen has not been reported in vivo, the ECM structure
found in the presumptive bone-implant interface may indeed
contain type X collagen. We speculate that the postulated ectopic
synthesis of cartilage ECMmay play a previously unreported role in
the establishment of osseointegration.
Conclusions
The present genome-wide microarray study of implant
ossoeintegation suggests that the specific microenvironment
induced by implant placement significantly affect a spectrum of
gene expression networks, possibly including peripheral circadian
Figure 4. The effect of implant disk and 1,25D supplementation on mouse bone marrow stromal cells (D1 cells) in vitro. A. D1 cells
cultured on polystyrene dish or implant disk with or without 1,25D supplementation (V+ and V2, respectively) were subjected to RT-PCR evaluation
of bone-and cartilage-related genes. B. The steady state mRNA levels of NPAS2 were assessed by RT-PCR under the same conditions. C. The
commercially available siRNA effectively knocked down the targeted NPAS2 in D1 cells cultured on polystyrene dish or implant disk with 1,25D
supplementation. The RT-PCR data were evaluated against the average control value in each group. *: p,0.05. D. The effect of NPAS2 knockdown on
the expression of type II and type X collagens. The RT-PCR data were evaluated using the average control value of D1 cells cultured on plastic dish as
the reference. *: p,0.05, against the control in each group.
doi:10.1371/journal.pone.0015848.g004
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Figure 5. Immunological identification of type X collagen associated with implant osseointegration. A. Mouse bone marrow stromal
cells (D1 cells) were cultured on implant disk (IT) or glass dish with or without 1,25D supplementation (V). Confocal laser scanning micrographs
depicted cell nuclei (DAPI: blue), cytoskeleton (b-actin: red) and type X collagen (green). B. The size of D1 cells was determined by the b-actin positive
Genome-Wide Screening of Osseointegration
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rhythm mechanisms. The potential interaction between NPAS2
and cartilage matrix genes has led to a hypothetical mechanistic
model of osseointegration that through the circadian rhythm-
related system, bone marrow mesenchymal cells may initiate
ectopic synthesis of cartilage matrix molecules including type X
collagen without the formation of in situ cartilage tissue. Vitamin D
deficiency negatively affects these processes, resulting in the lack of
bone and implant integration. Taken together, we postulate that
the establishment of osseointegration requires the peripheral
circadian rhythm system, which transiently activates the synthesis
of a selected set of cartilage matrix molecules possibly guiding the
intimate integration of implant surface and bone tissue.
Materials and Methods
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the University of California at Los
Angeles Chancellor’s Animal Research Committee (ARC 1997-
136). All surgery was performed under isoflurane inhalational
anesthesia, and all efforts were made to minimize suffering.
Experimental implants
T-shaped implants (external dimensions: 5.0 mm H63.0 mm
W62.0 mm D) [30,31] were fabricated from Ti4V6Al titanium
alloy and had a hollow inner chamber (3.0 mm H 63.0 mm W
61.0 mm D) (Figure 1A). The implant surface was treated by
dual acid-etching and received the discrete crystalline deposition of
HA nanoparticles (Biomet3i, Palm Beach Gardens, FL) [32]. Each
implant was gas sterilized and packaged separately.
Osteotomy and implant placement
Fourteen-week-old male Sprague-Dawley rats were fed with
either standard (#7013, Harlan Teklad, Madison, WI) or vitamin
D-deficient diet (0.47% Ca, 0.3% P) (#TD.89123, Harlan Teklad)
[29]. Both the control and the vitamin D-deficient groups were
housed in 12hr-dark/light cycles with fluorescent lighting lacking
ultraviolet B (UVB) irradiance. After 4 weeks, rats were further
assigned to the following four experimental groups: OSV+ (control
rats received osteotomy without the implant placement), OSV-
(vitamin-D deficient rats received osteotomy without the implant
placement), ITV+ (control rats received osteotomy and the
implant placement), and ITV- (vitamin D deficient rats received
osteotomy and the implant placement). Under 2% isoflurane
inhalation anesthesia, the implant site was prepared at 7 mm to
10 mm from the distal edge of the femur by a slow speed rotary
instrument under constant irrigation with sterile 0.9% NaCl
solution (Figure 1A). For the ITV+ and ITV- groups, a T-shaped
implant was placed into the osteotomy site until the implant roof
structure reached the femur exterior surface. For the OSV+ and
OSV- groups, an osteotomy with a size and depth same as the
implant dimensions was created without implant placement.
Animals were given 0.012 mg buprenorphine hydrochloride
(Buprenex Injectable, Reckitt Benckiser Healthcare Ltd., Hull,
England) after surgery, and drinking water was supplemented with
400 mg Sulfamethoxalole and 80 mg Trimethoprim (HI-TECH
Pharmacal Co. Inc., Amityville, NY)/500 ml water for 7 days.
Non-decalcified histology
Two weeks after the implant placement, the implant-femur
specimens of ITV+ (n=4) and ITV- (n=4) groups were harvested
and fixed in 10% buffered formalin. The tissue samples were
processed for histology without decalcification. Sections were cut
perpendicular to the T-shaped implant using motorized micro-
tome with diamond saw and stained with Goldner’s Masson
Trichrome protocol. Bone volume and bone-implant contact area
were measured within the inner chamber space using the
histomorphometric software (ImageJ-67, National Institutes of
Health, http://rsb.info.nih.gov/ij/).
Serum chemistry
At the time of sacrifice (6 weeks of the experimental period in
the OSV+, OSV-, ITV+ and ITV- groups), approximately 5–6 ml
of blood was extracted from each rat. Serum samples were
prepared and submitted to following measurements: 25-hydro-
xycholecalciferol (25D), calcium, phosphorus, magnesium, glu-
cose, triglycerides and parathyroid hormone (PTH).
Whole-genome microarray assay
Two weeks after implant placement, tissue samples inside the
implant hollow chamber were harvested under RNase-free
condition (ITV+: n=4; ITV-: n=4). Similarly, tissue samples
from osteotomy sites were harvested from the separate groups that
underwent the osteotomy but not implant placement (OSV+:
n=4; OSV-: n=4). The tissue sampling was consistently
performed between 10 am to 12 noon of the day. Subsequently,
the total RNA was extracted (miRNeasy Mini kit, Qiagen,
Valencia, CA, US) resulting in 16 independent total RNA
samples. The RNA concentration was quantified (NanoDropTM
1000 Spectrophotometer, Thermo Scientific, Wilmington, DE)
and the RNA quality was confirmed (Bioanalyzer 2000 system,
Agilent Technologies Inc., Santa Clara, CA).
Total RNAwas then subjected to a two-color channel microarray
(Agilent Rat Whole Genome, Agilent Technologies, Foster City,
CA) in order to screen the transcriptome profiles of more than
41,000 genes. The ‘‘reference pool’’ was prepared by combining
250 ng of the 4 RNA samples from the OSV+ group (total 1 mg) and
labeled with the Cy5 fluorescent dye. All the other experimental
replicates were individually labeled with the Cy3 fluorescent dye
(1 mg of total RNA) and further hybridized with the reference pool
sample. In the initial analysis, microarray hybridization and
detection underwent rigorous reproducibility tests (data not shown).
Microarray signal expression data were obtained using the Agilent
Feature Extraction Software (version 7.5.1). We used GeneSifter
software (www.genesifter.net) to pre-process and analyze micro-
array data. Data was expressed as Ratio Cy3/Cy5 instead of Cy3
and Cy5 intensities. LOWESS normalization method [55] was used
to improve the reliability of measuring relative differences across
samples, improving the precision and sensitivity.
Microarray Data Analysis Strategy
This study used stringent criteria to identify a network of genes
that are associated with the success and failure of implant
osseointegration by comparing bone wound healing and peri-
implant healing in two conditions: vitamin D sufficiency and
area per nucleus. The average cell size under different culture conditions was compared. *: p,0.05. C. T-shape implants were harvested 2 weeks after
the placement in femur of V+ rats and bone tissues were carefully removed from the external implant surface. In the highly cellular region depicted
by a cluster of nuclei (arrows; DAPI), type X collagen was not observed (upper left panel). In the transition region, type X collagen (green) showed a
similar appearance as in the in vitro culture (upper right panel). In the areas of exposed bone-implant interface, where no cells remained (lower
panels), type X collagen appeared to be involved in extracellular matrix with defined hexagonal structures (arrowhead).
doi:10.1371/journal.pone.0015848.g005
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deficiency. The whole genome microarray data were further
evaluated through the following data analysis strategy: first, the
microarray data were analyzed by two-way analysis of valiance
(ANOVA) with false discovery rate (FDR) correction to identify
significantly modulated gene transcripts for each factor. The
identified genes from two-way ANOVA were then categorized
into biologically relevant groups using the Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathway database. The two-way
ANOVA-identified genes were also separately evaluated by
hierarchical cluster analysis. Finally, a hypothetical mechanistic
model was established, which was tested in vitro.
Two-way ANOVA
Because our experiment design considered two factors: the healing
type (OS and IT) and the vitamin D condition (V+ and V-), the two-
way ANOVA evaluation was first applied for data analysis. For
interpretation of microarray data, it is important to reduce false
discoveries (type I errors) and increase the power to detect differences
in gene expression among the groups [56]. To this end, a list of
differently expressed genes was obtained from 4 independent
biological replicates in each group after the two-way ANOVA P-
values were adjusted for FDR with Benjamini and Hochberg
correction [57] with 95% confidence interval (Pcutoff = 0.05). We
considered the threshold of 2.0-fold change for differently expressed
transcripts and P,0.05 was considered significant.
Kyoto Encyclopedia of Genes and Genomes (KEGG)
Pathway analysis
Differently expressed transcriptomes were next analyzed by
KEGG Pathway analysis (http://www.genome.jp/kegg) to assign
genes into known biological pathways and reaction networks.
Pathways showing z-score above two (z-score $2.0) were
identified.
Hierarchical clustering analysis
All transcriptomes above 2.0-fold change by two-way ANOVA
were grouped into clusters. The hierarchical clustering was based
on Euclidean-Distance. Bootstrapping supported 1,000 dataset
resampling to generate consensus clusters. The hierarchical cluster
analysis was performed using MeV v4.3.01 (MultiExperiment
Viewer, TM4 Microarray Software Suite) (http://www.tm4.org/
mev.html).
RTPCR confirmation
RNA samples used for microarray study were tested with real
time reverse transcription polymerase chain reaction (RTPCR)
using commercially available Taqman-based primer/probe cock-
tails for selected genes representing bone extracellular matrix
(ECM): Col1a2 (Rn00670286_m1), osteonectin (Rn0147062-
4_m1), osteopontin (Rn00681031_m1); cartilage ECM: Col2a1
(Rn01637087_m1); and circadian rhythm: Per2 (Rn0142770-
4_m1). For Col10a1, the primer/probe cocktail was customly
designed based on ref. XM_001053056.1 (Applied Biosystems,
Carlsbad, CA).
Bone marrow mesenchymal stem cell culture on titanium
disks and vitamin D supplementation
Mouse bone marrow derived mesenchymal stem cells (D1 ORL
UVA [D1], ATCCH Number: CRL-s12424TM) were plated at a
density of 16,000 cells/well either on 48-well culture dishes
(Becton Dickinson Labware, Franklin Lakes, NJ) or on sterile 10-
mm Ti discs with surface of dual acid-etching and discrete
crystalline deposition of HA nanoparticles (Biomet3I) [32]. D1
cells were maintained with minimum Dulbecco’s Modified Eagle’s
medium (1X DMEM, Cellgro, Mediatech Inc., Manassas, VA)
supplemented with 10% fetal bovine serum (FBS, Benchmark,
Gemini Bio-Products, West Sacramento, CA), and 1% penicilin-
streptomicin (PS, MD Biomedicals, Thermo Fisher Scientific)
under a humidified atmosphere of 5% CO2 in air, 37uC. One day
after the cell seeding, the media was changed to osteogenic
differentiation medium (1X DMEM, 10% FBS, 1% PS, 10 mM
beta glycerol phosphate and 50 mM ascorbic acid) with or without
supplementation of 10 nM 1-alpha, 25-Dihydroxy-Vitamin D3
(1,25D, EMD Biosciences Inc., San Diego, CA). After 1, 3, 7 and
14 days of culturing in differentiation medium with or without
vitamin D supplementation, RNA was isolated from the cells
(RNeasy Mini kit, Qiagen). RT-PCR was performed using
Taqman protocol with commercially available primer/probe
cocktails (Applied Biosystems, Carlsbad, CA), for Col1a2
(Mm00483937_m1), osteonectin (Mm00486332_m1), Runx2
(Mm0302249_g1), Col2a1 (Mm01309565_m1), Col10a1
(Mm00487041_m1), Sox9 (Mm00448840_m1) and NPAS2
(Mm00500848_m1). Glyceraldehyde 3-dehydrogenase (GAPDH,
cat#4352338E or cat#Mm99999915_g1, Applied Biosystems)
was used as internal control.
In the separate study, the effect of NPAS2 knockdown on the
expression of cartilage ECM genes was examined. D1 cells were
cultured with or without the implant disc (10,000 cells/well). On
the second day, cells were incubated with commercially available
siRNA targeting NPAS2 or negative control siRNA (ID# s70729
and #4390843, respectively, Applied Biosystems) in the final
concentration of 23 nM with Lipofectamin 2000 (Invitrogen,
Carlsbad, CA). After 14 hours of siRNA incubation, cells were
washed and cultured for additional 2 days in the osteogenic
differentiation medium with 10 nM 1,25D supplementation. RNA
was isolated from the cells and RT-PCR was performed for
NPAS2, Col2a1, and Col10a1.
Immunological identification of type X collagen within
the implant osseointegration
For the in vitro study, D1 cells were cultured in glass chamber
slides (Lab Tek, Fisher Scientific, Pittsburgh, PA) or on titanium
disks under the same conditions described above. After 3, 7 and 14
days of culturing, cells were fixed with freshly prepared 3.7%
formaldehyde (methanol free) followed by the treatment with 0.2%
Triton X-100 in PBS glycine calcium and magnesium free (three
washes for 5 minutes) and Image-IT FX signal enhancer for 30
minutes (Invitrogen, Carlsbad, CA). The slides were incubated
over night with anti-type X collagen antibody (dilution 1:50,
ab58632, Abcam Inc., Cambridge, MA) followed by Alexa Fluor
488-conjugated secondary antibody for 45 minutes (dilution 1:500,
Invitrogen, Carlsbad, CA). To highlight cytoplasmic area,
specimens were incubated over night with anti-b actin antibody
(dilution 1:200, ab6276, Abcam Inc) followed by Alexa Fluor 568-
conjugated secondary antibodies for 45 minutes (dilution 1:500,
Invitrogen) or some specimens were incubated with Alexa Fluor
568-conjugated phalloidin (dilution 1:200). Primary and secondary
antibodies were diluted in 10% FBS, 0.5% BSA, 0.01% Triton X-
100 in calcium and magnesium free PBS. Samples were washed
three times in PBS calcium and magnesium free for five minutes
each after each incubation time. The slides were further treated
with DAPI (in mounting medium ProLongH Gold antifade
reagent, Cell Signaling, Invitrogen) and examined with a confocal
laser scanning microscope (Leica SP2 1P-FCS, Leica Camera AG,
Solms, Germany).
Confocal laser scanning micrographs were further subjected to
cell size measurement. The area of cytoplasma was depicted by
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cytoskeleton structure resulted from b-actin immunostaining. The
peripheral size of the cellular cytoplasma was measured from at
least 10 cells in each group using a digital image software (ImageJ
1.43, NIH, Bethesda, MD, USA). The data were compared by
Student’s t test with p,0.05 as significant.
For the in vivo study, T-shape implants (n = 4) were surgically
placed in rat femur as described above. After 2 weeks of healing,
implants were harvested and stored in RNA stabilizing reagent
(RNAlater, Ambion, Austin, TX) under 280uC. It has been
shown that the histology of tissues can be preserved by the RNA
stabilizing agent [58]. After gradual thawing, large bone tissues
were gently removed from the external surface of the implant
without scratching the surface. The T-shape implants with
remaining tissues were fixed for 15 minutes with freshly prepared
3.7% formaldehyde (methanol free). The method involving type X
collagen immunostaining and confocal laser scanning microscopy
was described above.
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